Targeting Wnt signaling in myeloma in vivo; Differential effects on tumor burden and myeloma bone disease

Míreanna comhchosúla

• Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo.
  de réir: Edwards, C, et al.
  Foilsithe / Cruthaithe: (2008)
• EphB4 Expression in Osteoblasts is Regulated by Myeloma Cells and the Wnt Signaling Pathway.
  de réir: Bates, A, et al.
  Foilsithe / Cruthaithe: (2008)
• Wnt signaling: bone's defense against myeloma.
  de réir: Edwards, C
  Foilsithe / Cruthaithe: (2008)
• Decreased bone marrow-derived adiponectin contributes to myeloma pathogenesis in vivo
  de réir: Fowler, J, et al.
  Foilsithe / Cruthaithe: (2010)
• Lithium inhibits the development of myeloma bone disease in vivo.
  de réir: Edwards, C, et al.
  Foilsithe / Cruthaithe: (2006)